BAKER BROS ADVISORS LLC 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-28 5:29 pm Purchase | 2020-07-21 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA | BAKER BROS ADVISORS LLC | 2,903,030 9.200% | 6,253 (+0.22%) | Filing |
| 2020-05-18 5:21 pm Purchase | 2020-05-13 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA | BAKER BROS ADVISORS LLC | 2,896,777 11.500% | 31,268 (+1.09%) | Filing |